On 2014 Jul 30, Jung Weon Lee commented:
The coauthor Kim S should be affiliated with "5 Therapeutic Antibody Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Republic of Korea", rather than "Department of Biological Sciences, Kangwon National University".
On 2014 Jul 31, Amanda Capes-Davis commented:
Thank you for your reply. Yes, it is important to use a range of cell line models. It is also important to spread the word that Chang cells are not an appropriate model for liver. Authentication testing using a method such as short tandem repeat (STR) profiling will help to confirm that cell lines used in experimental work are not misidentified.
On 2014 Jul 30, Jung Weon Lee commented:
In this study, many different liver cells in addition to HCC827 (NSCLC) and Chang cells were used in parallel.
On 2014 Jul 29, Amanda Capes-Davis commented:
Although they carry the name "Chang liver", these cells are not from normal liver. The Chang liver cell line is cross-contaminated with HeLa and is actually cervical adenocarcinoma. For a list of known cross-contaminated cell lines, see http://iclac.org/databases/cross-contaminations/.
On 2014 Jul 29, Amanda Capes-Davis commented:
Although they carry the name "Chang liver", these cells are not from normal liver. The Chang liver cell line is cross-contaminated with HeLa and is actually cervical adenocarcinoma. For a list of known cross-contaminated cell lines, see http://iclac.org/databases/cross-contaminations/.
On 2014 Jul 30, Jung Weon Lee commented:
In this study, many different liver cells in addition to HCC827 (NSCLC) and Chang cells were used in parallel.
On 2014 Jul 30, Jung Weon Lee commented:
The coauthor Kim S should be affiliated with "5 Therapeutic Antibody Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejon, Republic of Korea", rather than "Department of Biological Sciences, Kangwon National University".